Ajinomoto Heartland Inc. recently introduced a more concentrated form of AjiPro-L that delivers 25% more metabolizable lysine than the first-generation product.

The new AjiPro-L offers 80% rumen bypass and digestibility of more than 60% in the small intestine. Two plasma lysine studies, one at the University of New Hampshire and another at the W.H. Miner Institute, revealed that the new AjiPro-L was 30-40% more bioavailable than the first-generation product.